Vestmark Advisory Solutions’s Prime Medicine PRME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-78,599
| Closed | -$156K | – | 805 |
|
|
2025
Q1 | $156K | Sell |
78,599
-32,866
| -29% | -$65.4K | ﹤0.01% | 616 |
|
|
2024
Q4 | $460K | Buy |
111,465
+21,429
| +24% | +$88.4K | 0.02% | 422 |
|
|
2024
Q3 | $348K | Sell |
90,036
-13,476
| -13% | -$52.2K | 0.01% | 422 |
|
|
2024
Q2 | $532K | Sell |
103,512
-43,972
| -30% | -$226K | 0.02% | 393 |
|
|
2024
Q1 | $1.03M | Buy |
147,484
+3,196
| +2% | +$22.4K | 0.04% | 311 |
|
|
2023
Q4 | $1.28M | Buy |
+144,288
| New | +$1.28M | 0.06% | 264 |
|